I love that the focus is on dosage. I posted not a few days ago on how they determined 400mg and not higher was best. Given the good tolerability and strong responses we've seen so far, I hope they get to trial more dosages.
DYOR
Ann: Amplia Gains US Ethics Approval for Pancreatic Cancer Trial, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $116.7M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 24.5¢ | 24.0¢ | $616.5K | 2.554M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 550314 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 434493 | 11 |
View Market Depth
| Last trade - 11.57am 31/07/2025 (20 minute delay) ? |
| ATX (ASX) Chart |